Nong Ji Li

Nong Ji Li (Herba Crotalariae Sessiliflorae) is the dried aerial parts of Crotalaria sessiliflora L., an annual herbaceous plant in the family Fabaceae (legume family). In the traditional TCM classification system, Nong Ji Li is considered bitter in flavor with a neutral nature and is classified as toxic. It enters the Lung and Liver meridians. Historically, it has been used in folk medicine traditions in southern China for clearing Heat, resolving toxicity, stopping cough, and relieving pain. However, modern pharmacological research has identified significant safety concerns that have led many practitioners to avoid its use entirely.

Botanical description: Crotalaria sessiliflora is an erect or ascending annual herb growing 30–80 cm tall. The stems are slender, cylindrical, and green to greenish-brown, sometimes with a slight pubescence. The leaves are compound, alternate, with 3–5 leaflets per leaf; the leaflets are ovate to elliptic, 1.5–4 cm long and 0.8–2 cm wide, with entire margins and a short petiolule. The plant produces distinctive bright yellow flowers in terminal or axillary racemes; the flowers are papilionaceous, typical of the Fabaceae family, with a standard petal, two wing petals, and a keel. The fruit is an inflated, oblong legume pod, 1.5–2.5 cm long, containing numerous kidney-shaped seeds. The entire aerial part is harvested during flowering and dried in the sun or shade.

Habitat and distribution: C. sessiliflora is widely distributed across tropical and subtropical regions of Asia. In China, it is found in the southern provinces including Guangdong, Guangxi, Fujian, Yunnan, Guizhou, Hunan, and Jiangxi. The plant commonly grows in open fields, grassy slopes, roadsides, and waste areas at low to moderate elevations. It is also found in Japan, Korea, India, and Southeast Asian countries. The genus Crotalaria comprises over 600 species worldwide, many of which contain toxic pyrrolizidine alkaloids.

Quality markers and processing: Traditional quality standards for Nong Ji Li emphasize intact flowering aerial parts with bright yellow flowers and green leaves. The material should be free of mold, insect damage, and excessive stem material. Due to the known toxicity of pyrrolizidine alkaloids in this species, modern quality control should ideally include testing for monocrotaline and related PA content. Some traditional processing methods include stir-baking with vinegar or prolonged heating, which may partially reduce PA levels, but these methods are not standardized and do not reliably eliminate all hepatotoxic compounds. There are no established safe limits for monocrotaline content in Nong Ji Li preparations.

Taxonomic notes: Crotalaria sessiliflora is sometimes confused with other Crotalaria species, including C. assamica and C. spectabilis. All species in this genus should be treated with caution due to the widespread occurrence of pyrrolizidine alkaloids. Accurate botanical identification is essential, as PA content and profiles vary between species. The species name "sessiliflora" refers to the sessile (stalkless) nature of the flowers, which distinguishes it from some congeners with pedicellate flowers.

In the traditional Chinese medicine theoretical framework, Nong Ji Li is understood primarily as a folk medicine herb with applications in clearing Heat, resolving toxicity, stopping cough, and relieving pain. It is important to note that Nong Ji Li is not a major herb in the classical TCM canon and its uses are primarily documented in folk medicine traditions of southern China.

Clearing Heat and resolving toxicity: In TCM theory, Nong Ji Li has been used to clear Heat and resolve toxic-heat patterns. This includes conditions such as skin sores, carbuncles, boils, and abscesses that are attributed to the accumulation of toxic Heat in the body. In folk practice, the herb was sometimes applied topically as a paste or wash for these conditions. It was also used internally for snake bites and insect stings in folk traditions, reflecting its reputation as a toxicity-resolving agent. These traditional uses are based on folk experience and TCM pattern theory, not on controlled clinical evidence.

Stopping cough and relieving wheezing: Nong Ji Li has been traditionally used in some southern Chinese folk traditions for persistent cough and wheezing attributed to Lung Heat. The herb was prepared as a decoction or syrup for this purpose. It is important to emphasize that the herb's traditional reputation for treating respiratory conditions does not outweigh the known hepatotoxic risks associated with pyrrolizidine alkaloid ingestion. Safer alternatives for cough and respiratory complaints are widely available in the TCM materia medica.

Relieving pain: Some folk medicine traditions attribute analgesic properties to Nong Ji Li, using it for headaches, stomachache, and joint pain. These uses are documented in regional materia medica compilations but are not supported by robust clinical evidence. The mechanism of any analgesic effect is unclear, and the risk-benefit ratio for using this herb internally for pain management is overwhelmingly negative given the hepatotoxicity of its pyrrolizidine alkaloid constituents.

Historical and regional literature references: Nong Ji Li is documented in several regional Chinese materia medica works, including the Guangxi Materia Medica and the Fujian Materia Medica, where it is described as a folk herb for clearing Heat, resolving toxicity, and treating sores. The Zhonghua Bencao (Chinese Materia Medica) lists it with a toxicity warning. Modern Chinese pharmacopoeial texts have progressively moved away from recommending internal use of Nong Ji Li due to accumulating evidence of PA hepatotoxicity. Contemporary TCM educational resources generally classify this herb as one to be avoided in clinical practice.

Nong Ji Li contains a range of bioactive compounds, with pyrrolizidine alkaloids (PAs) being the most significant and concerning class of constituents. The following overview summarizes the major chemical constituents identified in Crotalaria sessiliflora and what is currently known about them from published research.

Monocrotaline: Monocrotaline is a hepatotoxic 1,2-unsaturated pyrrolizidine alkaloid and the primary toxic constituent of Nong Ji Li. It is a protoxigenic PA that is metabolized in the liver by cytochrome P450 enzymes (particularly CYP3A4 and CYP2B6) to form reactive pyrrolic metabolites (dehydro-monocrotaline, also called dehydropyrrolizine or DHP). These reactive intermediates bind covalently to cellular proteins and DNA, causing hepatocellular necrosis, sinusoidal endothelial cell damage, and progressive fibrosis of the hepatic venules — the hallmark of hepatic veno-occlusive disease. Monocrotaline is also well-known for its ability to induce pulmonary arterial hypertension in animal models, making it a widely used tool compound in cardiovascular research. The LD50 of monocrotaline in rats is approximately 50–100 mg/kg (intraperitoneal), depending on the study.

Monocrotaline N-oxide: Monocrotaline N-oxide is the N-oxide derivative of monocrotaline and is typically present at higher levels than the parent alkaloid in fresh plant material. While the N-oxide itself is less toxic than the parent base, it can be reduced back to monocrotaline in the mammalian gut by bacterial nitroreductases, effectively serving as a latent source of the toxic parent alkaloid. This metabolic retro-reduction in the gut is a well-documented mechanism by which PA N-oxides contribute to overall PA toxicity. Monocrotaline N-oxide is water-soluble and may be partially removed by aqueous extraction methods, but this does not reliably detoxify the herb.

Usaramine: Usaramine is another pyrrolizidine alkaloid found in Crotalaria species. Like monocrotaline, usaramine is a 1,2-unsaturated PA that can form hepatotoxic pyrrolic metabolites upon metabolic activation. It contributes to the overall PA burden and toxicity of Nong Ji Li. Usaramine has been studied for its cytotoxic and genotoxic properties in pre-clinical models, confirming its potential to cause DNA cross-linking and cellular damage.

Flavonoids: Several flavonoid compounds have been isolated from the non-alkaloid fraction ofCrotalaria sessiliflora, including apigenin, luteolin, and their glycoside derivatives. These flavonoids have been studied for antioxidant and anti-inflammatory properties in pre-clinical research. However, they are present in relatively small quantities compared to the PA fraction, and their potential benefits are far outweighed by the toxicity of the pyrrolizidine alkaloids in the same plant. The presence of flavonoids does not mitigate the hepatotoxic risk associated with PA ingestion.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans. The pyrrolizidine alkaloids in Nong Ji Li are well-documented hepatotoxins with human toxicity case reports.

Nong Ji Li is not a standard ingredient in the major classical TCM formula compendiums. Its use has been primarily in folk medicine preparations from southern China. Below are three historically documented folk preparations that feature Nong Ji Li, along with descriptions of their traditional context and intended applications.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Monocrotaline-induced hepatotoxicity and HVOD: The hepatotoxic mechanism of monocrotaline has been extensively studied. Monocrotaline is metabolically activated by hepatic CYP3A4 and CYP2B6 to form dehydro-monocrotaline (DHP), a reactive electrophile that covalently binds to cellular macromolecules. DeLeve et al. (1999) demonstrated that monocrotaline selectively damages hepatic sinusoidal endothelial cells, leading to the characteristic occlusive lesions of HVOD (PMID: 10385609). More recent work by Wang et al. (2019) showed that monocrotaline-induced SOS is associated with disruption of the SEC glycocalyx and activation of coagulation pathways in the hepatic sinusoids (PMID: 30872833). Javanmard et al. (2023) reviewed PA-induced hepatotoxicity mechanisms and emphasized that metabolic activation by CYP450 enzymes is the critical step in PA toxicity, with individual variation in CYP activity affecting susceptibility (PMID: 36838707).

Monocrotaline as a PAH research tool: Monocrotaline is widely used in pre-clinical research to induce pulmonary arterial hypertension (PAH) in animal models. Stenmark et al. (2009) reviewed the monocrotaline model of PAH, noting that it reproduces many features of human PAH including pulmonary vascular remodeling, right ventricular hypertrophy, and increased pulmonary arterial pressure (PMID: 19556526). Gomez-Arroyo et al. (2012) characterized the time course of monocrotaline-induced PAH in rats, documenting progressive vascular remodeling from endothelial injury to obliterative intimal lesions (PMID: 22539529). While these studies contribute to PAH research, they underscore the potency of monocrotaline as a toxic agent and reinforce the advisability of avoiding Nong Ji Li consumption.

Pyrrolizidine alkaloid contamination and regulation: International regulatory bodies have established limits for PA content in herbal products and foodstuffs. The European Medicines Agency (EMA) issued guidelines in 2020 recommending that the daily intake of 1,2-unsaturated PAs from herbal medicinal products should not exceed 0.007 micrograms/kg body weight per day, based on a genotoxicity-based threshold of toxicological concern (TTC) approach (PMID: 33420236). This extremely low threshold reflects the genotoxic and carcinogenic potential of PAs. Mulder et al. (2018) identified a biomarker of PA exposure — pyrrole-protein adducts in blood — that allows detection of PA exposure even weeks after ingestion (PMID: 29788921). These regulatory and biomarker developments underscore the serious nature of PA toxicity from herbs like Nong Ji Li.

Potential protective strategies against PA toxicity: Research has explored potential protective agents against monocrotaline-induced toxicity. Lin et al. (2018) demonstrated that glutathione depletion sensitizes cells to monocrotaline toxicity, while N-acetylcysteine supplementation provided partial protection in vitro (PMID: 29661248). Schrenk et al. (2020) reviewed detoxification pathways for PAs, noting that hepatic glutathione conjugation and hydrolysis represent potential routes for PA detoxification, but these pathways are saturable and insufficient to prevent toxicity at higher exposure levels (PMID: 32043319). These protective strategies are relevant only in controlled experimental settings and do not make Nong Ji Li safe for consumption.

What the research does NOT show: Despite some research interest in Nong Ji Li's minor constituents (flavonoids), there is NO credible evidence from randomized, placebo-controlled clinical trials that Nong Ji Li can safely or effectively treat any medical condition in humans. The hepatotoxicity of its pyrrolizidine alkaloid constituents is well-established and represents an unacceptable risk for therapeutic use. There is no safe dose that has been established for internal consumption. This page does not endorse Nong Ji Li as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). The toxicity of pyrrolizidine alkaloids in Nong Ji Li is well-documented in both pre-clinical and human case reports. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile — AVOID: Nong Ji Li is classified with an "avoid" safety rating due to the presence of hepatotoxic pyrrolizidine alkaloids, particularly monocrotaline. This is the most serious safety classification applied to herbs on this platform. The hepatotoxicity of monocrotaline and related PAs is well-documented in both pre-clinical research and human case reports of PA poisoning. The damage caused by HVOD can be irreversible and may require liver transplantation in severe cases.

Hepatic veno-occlusive disease risk: The primary and most serious risk associated with Nong Ji Li is hepatic veno-occlusive disease (HVOD), also known as sinusoidal obstruction syndrome (SOS). This condition results from the metabolic activation of monocrotaline to reactive pyrrolic intermediates that damage hepatic sinusoidal endothelial cells, leading to fibrosis and occlusion of the hepatic venules. Symptoms of HVOD include abdominal pain, hepatomegaly, ascites, jaundice, and progressive liver failure. The onset may be delayed by 2–6 weeks after ingestion, making it difficult to connect symptoms to the causative exposure. HVOD has a significant mortality rate, particularly in severe cases.

Pregnancy and lactation — absolutely contraindicated: Nong Ji Li is absolutely contraindicated during pregnancy and lactation. Pyrrolizidine alkaloids are known to be genotoxic and potentially carcinogenic. There is evidence that PAs can cross the placental barrier, and fetal exposure to hepatotoxic PAs has been associated with fetal liver damage. PAs may also be excreted in breast milk, posing a risk to nursing infants. Under no circumstances should Nong Ji Li be used during pregnancy or lactation.

Children — absolutely contraindicated: Children are particularly vulnerable to the hepatotoxic effects of pyrrolizidine alkaloids due to their lower body mass and developing hepatic metabolic systems. Cases of HVOD in children following PA exposure have been documented in the medical literature, including outbreaks associated with consumption of PA-contaminated herbal teas and grain products. Nong Ji Li should never be given to children.

Pre-existing liver disease: Individuals with pre-existing liver conditions, including hepatitis, cirrhosis, fatty liver disease, or any form of hepatic impairment, are at heightened risk from PA toxicity. The liver's reduced functional reserve makes it less able to cope with additional toxic injury, increasing the risk of fulminant liver failure. Nong Ji Li is absolutely contraindicated in individuals with any form of liver disease.

Drug interactions: Monocrotaline is metabolized by CYP3A4 and CYP2B6. Drugs that induce these enzymes (such as rifampicin, phenobarbital, and St. John's Wort) could potentially increase the rate of metabolic activation of monocrotaline, increasing hepatotoxicity. Conversely, CYP inhibitors might theoretically reduce metabolic activation, but this is not a reliable protective strategy and the variability makes dosing impossible to predict. The complexity of PA metabolism and the impossibility of predicting safe doses make drug-herb interactions with Nong Ji Li particularly concerning.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Nong Ji Li or any other herbal product for the treatment of any medical condition. Due to its hepatotoxic pyrrolizidine alkaloid content, Nong Ji Li is strongly discouraged for use. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider. This information is educational only, not medical advice.